IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.270
-0.004 (-0.31%)
Jul 24, 2026, 5:29 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 189.46 million as of July 24, 2026. Its market cap has decreased by -33.61% in one year.
Market Cap
189.46M
Enterprise Value
165.76M
Revenue
92.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.27
ChartMarket Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 189.46M, a decrease of -54.13%. That is a compound annual growth rate of -7.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 189.46M | 13.23% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 232.04M |
| Xbrane Biopharma AB | 206.05M |
| Simris Group AB (PUBL) | 182.22M |
| Elicera Therapeutics AB | 175.52M |
| Initiator Pharma | 167.03M |
| Xintela AB | 162.78M |
| Diamyd Medical AB | 162.42M |
| Nanologica AB | 144.00M |